MX170285B - Composiciones cosmeticas y para el tratamiento de la piel - Google Patents

Composiciones cosmeticas y para el tratamiento de la piel

Info

Publication number
MX170285B
MX170285B MX016507A MX1650789A MX170285B MX 170285 B MX170285 B MX 170285B MX 016507 A MX016507 A MX 016507A MX 1650789 A MX1650789 A MX 1650789A MX 170285 B MX170285 B MX 170285B
Authority
MX
Mexico
Prior art keywords
carbon atoms
cosmetic
moieties containing
skin treatment
treatment compositions
Prior art date
Application number
MX016507A
Other languages
English (en)
Inventor
Loren R Pickart
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/207,698 external-priority patent/US5135913A/en
Application filed by Procyte Corp filed Critical Procyte Corp
Publication of MX170285B publication Critical patent/MX170285B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una composición, caracterizada porque comprende GHL-Cu o un derivado de GHL-Cu que tiene la fórmula general: [glicil-L-histidil-L-lisina-C--R] en donde R se selecciona del grupo que consiste de porciones alquilo que contienen de 1 a 18 átomos de carbono, porciones arilo que contienen de 6 a 12 atomos de carbono, porciones alcoxi que contienen de 1 a 18 atomos de carbono y porciones ariloxi que contienen de 6 a 12 atomos de carbono, o en donde R es L-prolil-L-fenilalanil-L-valina o L-valil-l-fenil-alanil-L-valina, en combinacion con un vehiculo o diluyente cosmetica y dermatologicamente aceptables.
MX016507A 1988-06-16 1989-06-16 Composiciones cosmeticas y para el tratamiento de la piel MX170285B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/207,698 US5135913A (en) 1987-05-11 1988-06-16 Cosmetic and skin treatment compositions

Publications (1)

Publication Number Publication Date
MX170285B true MX170285B (es) 1993-08-13

Family

ID=22771631

Family Applications (1)

Application Number Title Priority Date Filing Date
MX016507A MX170285B (es) 1988-06-16 1989-06-16 Composiciones cosmeticas y para el tratamiento de la piel

Country Status (12)

Country Link
EP (1) EP0420914B1 (es)
JP (1) JP2951345B2 (es)
KR (1) KR900701250A (es)
AU (1) AU633005B2 (es)
CA (1) CA1335568C (es)
DE (1) DE68913739T2 (es)
DK (1) DK295190A (es)
FI (1) FI906183A0 (es)
GR (1) GR1002802B (es)
MX (1) MX170285B (es)
NO (1) NO179195C (es)
WO (1) WO1989012441A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
SE465154B (sv) * 1990-02-06 1991-08-05 Lars Strid Tillvaextfaktor i samband med artificiella transplantat
US5386012A (en) * 1990-02-06 1995-01-31 Strid; Lars Growth factor in connection with artificial implants
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
FR2706300B1 (fr) * 1993-06-17 1995-09-01 Dior Christian Parfums Utilisation d'un peptide ayant un groupement lysine et un groupement alanine en position terminale pour la préparation d'une composition dépigmentante et composition dépigmentante en comportant application.
EP0755256A4 (en) * 1994-03-28 1997-09-03 Skin Biology Inc STARCH-METAL COMPLEXES FOR SKIN AND HAIR
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
SE9500270L (sv) * 1995-01-25 1996-09-09 A K J Medi Konsult Ab Läkemedel mot bristtillstånd
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
FR2802413B1 (fr) * 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
EP1534215A1 (en) * 2002-07-02 2005-06-01 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
WO2004099237A1 (de) * 2003-05-08 2004-11-18 Pentapharm Ag Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
WO2006018198A1 (de) * 2004-08-13 2006-02-23 Henkel Kommanditgesellschaft Auf Aktien Kosmetische und dermatologische zusammensetzungen mit (2-hydroxyethyl)harnstoff
US20060052287A1 (en) * 2004-08-18 2006-03-09 Procyte Corporation Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
US7618662B2 (en) * 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
JP2021000761A (ja) * 2019-06-21 2021-01-07 ロレアル 化粧インク塗布装置および化粧インクを塗布する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu
ATE103608T1 (de) * 1987-04-20 1994-04-15 Procyte Corp Chemische derivate von ghl-cu.
WO1988008695A1 (en) * 1987-05-11 1988-11-17 Procyte Corporation Methods for stimulating hair growth
GB8711473D0 (en) * 1987-05-15 1987-06-17 Lange J Support mechanism

Also Published As

Publication number Publication date
KR900701250A (ko) 1990-12-01
WO1989012441A1 (en) 1989-12-28
DK295190A (da) 1991-02-15
NO179195C (no) 1996-08-28
JP2951345B2 (ja) 1999-09-20
GR890100404A (el) 1990-05-11
EP0420914A1 (en) 1991-04-10
CA1335568C (en) 1995-05-16
DE68913739T2 (de) 1994-06-23
DK295190D0 (da) 1990-12-12
NO179195B (no) 1996-05-20
NO905421L (no) 1991-02-13
DE68913739D1 (de) 1994-04-14
FI906183A0 (fi) 1990-12-14
AU633005B2 (en) 1993-01-21
NO905421D0 (no) 1990-12-14
JPH03505872A (ja) 1991-12-19
EP0420914B1 (en) 1994-03-09
GR1002802B (el) 1997-11-10
AU3768789A (en) 1990-01-12

Similar Documents

Publication Publication Date Title
MX170285B (es) Composiciones cosmeticas y para el tratamiento de la piel
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DE59204623D1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
ZA869497B (en) Antimycotic nail varnish
BG92804A (bg) 4-бензоилизоксазолови производни
DK485788D0 (da) Kosmetisk praeparat
MY101066A (en) Cosmetics
DE3580124D1 (de) Pyridobenzothiazinderivate mit hoch antimikrobieller wirkung.
FR2384805A1 (fr) Sels de polyesters lineaires
ES2195184T3 (es) Preparaciones cosmeticas.
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ES2084371T3 (es) Composiciones cosmeticas que contienen un extracto de eclipta alba.
ATE53941T1 (de) Verwendung von sophoroselipid-lacton zur bekaempfung von kopfschuppen und koerpergeruch.
MX165348B (es) Composicion inhibidora de polimerizacion para compuestos vinilaromaticos
AU6570186A (en) Novel pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity and synthesis and use thereof
ATE198142T1 (de) Haarfestlegemittel
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
KR950025035A (ko) 코지산 유도체
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
ATE108325T1 (de) Hautbleichende kosmetika.
DE69316324D1 (de) 4-Hydroxy-phenyl-beta-D-glukose-monoester, Verfahren zur ihrer Herstellung und ihre Verwendung in der Kosmetik, der Pharmazie, als Zahnpflegemitteln und Lebensmitteln
PT90483A (pt) Processo para a proteccao de produtos alimentares contra a oxidacao
ES2014445B3 (es) Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.
ES8101065A1 (es) Procedimiento para la obtencion de 4,6-dioxa-5-alquil-trici-clo(7.2.1.0 2,8)-dodec-10-enos, de efecto aromatizante
ES8505984A1 (es) Procedimiento de preparar 2,9-dihidrofuranos